Sai Life Sciences IPO Allotment Status

13 Dec 2024|

1 min read |

by ICICI Securities Team

The Sai Life Sciences IPO allotment status allows investors to find out if they received shares after applying for Sai Life Sciences Initial Public Offering (IPO). Once the IPO subscription period closes, the allotment status is usually available within a few days. Investors can check their allotment through several methods, including the registrar’s website, the Bombay Stock Exchange (BSE), or by looking at their Demat or bank account.

Sai Life Sciences IPO Allotment Date

Investors who applied for the Sai Life Sciences IPO can expect the allotment results on Monday, December 16, 2024. If you're allotted shares, they will be credited to your Demat account, and the corresponding amount will be debited from your linked bank account. Keep an eye on your preferred method to check the status once the allotment is processed on the announced date.

How to Check Sai Life Sciences IPO Allotment Status on the Registrar's Site?

Visit the registrar's website (https://ris.kfintech.com/ipostatus/)
Select Sai Life Sciences IPO from the list of available issues.
Enter your application number, PAN, or DP/Client ID.
Click on submit to view the allotment status.

The registrar's website allows you to track your application status, and you can view whether you were allotted any shares.

How to Check Sai Life Sciences IPO Allotment Status on BSE

Visit the BSE website. (https://www.bseindia.com/investors/appli_check.aspx)
Select "Equity" and then Sai Life Sciences IPO from the dropdown menu
Enter your application number or PAN
Verify the status by entering the correct captcha code and clicking "Search."

You will see the allotment result indicating if shares were allotted or not.

How to Check Sai Life Sciences IPO Allotment Status in a Bank Account

Check your registered bank account for any automatic deductions related to the IPO.
If the amount is debited from your account, it indicates share allotment.
If the amount is not debited, it suggests that no shares are alloted to you.

You can also log into your bank's net banking to verify any related transactions.

How to Check Sai Life Sciences IPO Allotment Status on ICICI Direct

Website: https://www.icicidirect.com

Log in to your ICICI Direct account
Head to "IPO" section and go to orderbook
You can check the number of allotted shares under share/bonds allotted column against the Sai Life Sciences IPO

APP

Open the ICICI Direct app and log in.
Navigate to the "IPO" section
Select Sai Life Sciences IPO to check the allotment status.

The blocked amount gets debited within 24hrs of shares allotment announcement and the shares are allotted to the users on the day of listing. Once the company gets listed on NSE & BSE, the shares are available for trading purposes.

Sai Life Sciences IPO Subscription Status

The Sai Life Sciences IPO subscription status indicates the level of interest in the IPO across different investor categories. Here is the subscription breakdown:

Subscription Day 1 (11 December, 2024)	Subscription Day 2 (12 December, 2024)	Subscription Day 3 (13 December, 2024)
Total Subscription: 0.85 times	Total Subscription: 1.26 times	Total Subscription: 10.27 times
QIBs: 2.52 times	QIBs: 3.20 times	QIBs: 29.78 times
Non-institutional investors: 0.16 times	Non-institutional investors: 0.60 times	Non-institutional investors: 4.99 times
Retail investors: 0.19 times	Retail investors: 0.43 times	Retail investors: 1.39 times

Disclaimer

ICICI Securities Limited has its registered office at ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400025, India, Tel No:- 022 - 2288 2460, 022 - 2288 2470. The non-broking products / services like iLearn and Financial Learning are not exchange traded products / services and ICICI Securities Ltd. is just acting as a distributor/ referral Agent of such products / services and all disputes with respect to the distribution activity would not have access to Exchange investor redressal or Arbitration mechanism. iLearn is not an exchange traded product/service of ICICI Securities Ltd. All disputes with respect to the activity on the platform would not have access to Exchange investor redressal or Arbitration mechanism.

ICICI Securities Ltd. is a Member of National Stock Exchange of India Ltd (Member Code :07730), BSE Ltd (Member Code :103) and Member of Multi Commodity Exchange of India Ltd. (Member Code: 56250) and having SEBI registration no. INZ000183631. ICICI Securities Ltd. is a SEBI registered with SEBI as a Research Analyst vide registration no. INH000000990. Name of the Compliance officer (broking): Ms. Mamta Shetty, Contact number: 022-40701022, E-mail address: complianceofficer@icicisecurities.com Investments in securities markets are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. ICICI Securities Ltd. and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Such representations are not indicative of future results. The securities quoted are exemplary and are not recommendatory. AMFI Regn. No.: ARN-0845. PFRDA registration numbers: POP no -05092018. ICICI Securities Ltd. acts as a Composite Corporate agent having registration number –CA0113. Mutual Fund Investments are subject to market risks, read all scheme related documents carefully. Please note, Mutual Fund, Corporate Fixed Deposits, Bonds, Alternate investment funds, Tax planning, Succession planning, NPS, IPO, Investment Advisory and Loans related services are not Exchange traded products and ICICI Securities Ltd. is acting as a distributor to solicit these products. Please note, Insurance related services are not Exchange traded products and ICICI Securities Ltd. is acting as a corporate agent to solicit these products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The non-broking products / services like Research, etc. are not exchange traded products / services and all disputes with respect to such activities would not have access to Exchange investor redressal or Arbitration mechanism. The contents herein above are solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments or any other product. Investors should consult their financial advisers whether the product is suitable for them before taking any decision. The contents herein mentioned are solely for informational and educational purpose.